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 INTRODUCTION  
 
 
 
 
 
 
 INTRODUCTION 
 
Dengue is the most common important arthropod-borne viral 
(arboviral) illness in humans which is transmitted by mosquitoes of the 
genus Aedes, which are widely distributed in subtropical and tropical areas 
of the world . The incidence of dengue has increased dramatically in recent 
decades, with estimates of 40%-50% of the world’s population at risk for 
the disease in tropical, subtropical, and, most recently, more temperate 
areas. A small percentage of persons who have previously been infected by 
one dengue serotype develop bleeding and endothelial leak upon infection 
with another dengue serotype. This syndrome is termed severe dengue (also 
known as dengue hemorrhagic fever and dengue shock syndrome).  
Dengue fever is typically a self-limited disease with a mortality rate 
of less than 1% when detected early and with access to proper medical care. 
When treated, severe dengue has a mortality rate of 2%-5%, but, when left 
untreated, the mortality rate is as high as 20%. 
 
Justification of the study: 
 
Dengue fever is one of the major epidemic that the state faces every 
year. Dengue shock syndrome and dengue haemorragic fever being the 
deadly form of the disease. Hence close monitoring of the patients are 
needed to manage with adequate hydration to prevent a profound dengue 
shock syndrome. Monitoring of the patients are usually done with 
 laboratory parameters like platelet count, PCV and clinical monitoring of 
Blood pressure. An ultrasonography of chest abdomen abdomen pelvis  
along with the clinical and laboratory data can assist in assesing the 
severity of plasma leakage and can detect evidence of plasma leakage 
earlier. Hence appropriate management can be done to prevent a shock  
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 OBJECTIVE: 
 
To find the prognostic value of ultrasonography in Dengue fever compared 
with clinical and laboratory parameters 
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 REVIEW OF LITERATURE:  
Dengue fever, also known as , breakbone fever - identified as the 
most common arboviral (arthropod-borne) disease worldwide by WHO.  
 It is transmitted by female mosquitoes of the genus Aedes, It is 
mostly in subtropical and tropical geographical distribution.There are 5 
antigenically distinct serotypes – (DENV 1-5). The 5th serotype was 
discovered in October 2013 in malaysia.(sylvatic)  
 There is a 30-fold increase in global incidence over the last 
five decades. According to WHO, recent estimate indicates 390 million 
dengue infections annually ,of which 96 million manifest clinically. About  
3.5-5 lakh cases of DHF/DSS cases occur  per year .About 3900 million 
people, in 128 countries, are at risk of infection. The 75% of global disease 
burden is in Asia-Pacific region. Actual no. of dengue cases are 
underreported/misclassified. • Dengue virus was isolated in India for the 
first time in 1945.  
  Indian scenario; The first recorded epidemic of clinically 
Dengue like illness in India occurred at Madras in 1780. The first evidence 
of occurrence of dengue fever in the country was reported in 1956 from 
Vellore district in Tamil Nadu. The first dengue hemorrhagic fever(DHF) 
outbreak occurred in Calcutta in 1963.  
  All 4 serotypes are found in Indian population. Since 1996, the area 
of endemicity is increasing with about 450 million population at risk. At 
present, dengue is endemic in 23 states of India. Mortality rates are 10-20% 
(40% in case of DSS) Incidence increased 30-fold in last 50 years due to: 
1) Climatic change 
2)  Uncontrolled population growth 
3)  Improper water storage 
4)  Rapid & unplanned urbanization   
 5)  Increase in air travel 
    Which all lead to increased proliferation of vector and increased 
virus transmission.  
Epidemiology depends on 3 factors : 
1) Agent – virus. 
2) Environment. 
3) Host – man & mosquito. 
AGENT- Dengue virus   
Dengue virus belongs the genus flavivirus. These viruses contain a 
single stranded RNA as its genome and are small in size (30-45nm).There 
are five antigenically distinct serotypes (DENV 1-5) with abundant genetic 
variation. These serotypes may be in circulation either in singular, or more 
than one can be in circulation in any geographical area at the same time. 
  Antigens can cross react with other members in the same genus. 
Infection with any one serotype confers lifelong immunity to the virus 
serotype.  
The genome of Dengue virus encodes only 10 proteins. Out of ten, 3 
are structural proteins that form the coat of the virus and deliver the RNA 
to target cells – 
1) 1k4r ,the nucleocapsid of core protein, 
2) 1ok8, a membrane associated protein (M), 
3) 2r6p6, an envelope protein(E). 
7 are non-structural (NS) proteins that orchestrate the production of new 
viral antigens once the virus invades the cell - NS1, NS2A, NS2B, NS3, 
NS4A, NS4B and NS5  
In dengue virus infection, pts have measurable levels of NS1 protein 
in the blood, which is a diagnostic marker of the infection. 
 
VECTOR-INTERMEDIATE HOST – Aedes  
 DENV is transmitted by the bite of female Aedes mosquito. In 
India, Aedes aegypti is the main vector in most urban areas. Rarely by 
Ae.Albopictus, Ae.polynesiensis, Ae.niveus in some states. Population 
& Lifespan of the mosquito depends on - rainfall, water storage, 
temperature and humidity.  
 Aedes shows year round breeding – (10oC Isotherm).  It is 
distributed over 300 N to 400 S latitude, that is involving the Tropics and 
sub-tropics. It survives best between 16oC and 30oC and a relative 
humidity of 60-80%.  
Altitude is also a limiting factor for the distribution and is restricted 
to between sea level and 1000 ft above sea level.  
To find a host, these mosquitoes are attracted to chemical 
compounds emitted by mammals. These compounds include ammonia, 
carbon dioxide, lactic acid, and octenol. Most commonly it bites at dusk 
and dawn, indoors & in shady areas. 
It breeds in areas of stagnant water, such as flower vases, uncovered 
barrels, buckets, and discarded tires, but the most dangerous areas are wet 
shower floors and toilet tanks, as they allow the mosquitos to breed in the 
residence. 
Research has shown that certain chemicals (fatty acids associated 
with bacteria involved in the degradation organic matter in water) stimulate 
the female mosquitoes to lay their eggs.It can transmit the infection trans-
ovarially. 
 
 
 
 HOST – Humans 
 The DENV infects humans and several species of lower 
primates. People of all ages and both genders are at risk. (more in <15 yrs 
age groups & in females). Secondary dengue infection is a risk factor for 
DHF, including passively acquired antibodies in infants. Travel to dengue 
endemic areas is a most important risk factor. Migration of a patient during 
viremia to a non-endemic area may introduce dengue into that area. The 
geographical spread of dengue has been reported to occur mainly by people 
travelling from endemic areas to non-endemic areas. 
 
TRANSMISSION 
 
Because of the high level of viraemia resulting from Dengue 
infection of humans, the viruses are efficiently transmitted between 
mosquitoes and humans without the need for an enzootic/sylvantic 
amplification host 
  
 
PATHOGENESIS OF DENGUE HAEMORRAHGIC FEVER 
Homologous Antibodies Form Non- infectious Complexes during the 
first attack of Dengue fever. 
Heterologous Antibodies of first serotype infection form Infectious 
Complexes with second serotype in case of second infection 
 Heterologous Complexes Enter More Monocytes & macrophages, 
Where Virus Replicates. The affected macrophages release vasoactive 
mediators that increase vascular permeability, leading to vascular leakage, 
hypovolemia, and shock. 
 Infants born to mothers who have had dengue, as maternally derived 
dengue neutralizing IgGs wane, are also thought to be at risk for enhanced 
disease. Activation of classic complement pathway & Cross reactivity at T-
cell level results in increased production of IFN-γ & TNF-α leading to 
Increased vascular permeability & bleeding. Antibody dependent 
enhancement (ADE) & inappropriate memory T-cell response are central to 
pathogenesis of DHF/DSS. 
 
Abnormal hemostasis : 
1. Vasculopathy 
2. Thrombopathy with impaired platelet function & moderate-severe 
thrombocytopenia (due to interaction of virus with platelets 
through IgM antiplatelet antibody) 
3. Coagulopathy, with activation of coagulation & fibrinolysis, and 
later in severe disease,DIC. 
4. Bone Marrow depression – reduced megakaryocyte production 
5.    Suppressed megakaryocytopoiesis & increased platelet clearance 
by DENV induced apoptosis & antiplatelet antibodies. 
Factors influencing Dengue haemorrhagic syndrome: 
 • Presence of enhancing and non neutralising antibodies 
 • Age : susceptibility to DHF/DSS drops significantly after 12 yrs 
of age 
• Sex : females more often affected than males 
• Race : Caucasians more often affected than blacks 
• Nutritional status : malnutrition is protective 
• Sequence of infection : example, serotype 1 followed by 
serotype 2 is more dangerous than serotype 4 followed by 
serotype 2 
• Infecting serotype : type 2 more dangerous than others 
• Infecting genotype : Asian type 2 causes DHF/DSS while 
American type is not responsible for the illness 
 
Dengue clinical syndromes 
1. Undifferentiated fever 
2. Classic Dengue fever 
3. Dengue haemorrhagic fever 
4. Dengue shock syndrome 
 
 
 
 
 
 
 Dengue infection 
 
Probable dengue 
Live in or travel to a dengue endemic area 
Fever and any 2 of the following 
1) Nausea ,vomiting 
2) Rashes 
3) Aches and pains 
4) Tourniquet test positive 
5) leukopenia 
6) Any warning sign 
 
 Warning signs  
1) Abdominal pain or tenderness 
2) Persistent vomiting 
3) Clinical fliud accumulation 
4) Mucosal bleed 
5) Lethargy , restlessness 
6) Liver enlargement more than 2 cms 
7) Lab: increase in hematocrit concurrent with a decrease in platelet 
count 
Severe dengue infection 
1) Severe plasma leakage 
leading to shock 
          fluid accumulation leding to repiratory distress 
2) Severe bleeding 
3) Severe organ involvement 
Liver  Ast or ALT more than 1000 
CNS – impaired consciousness 
Heart or other organs 
NATURAL  COURSE  
The clinical course of illness passes through 3 phases: 
• Febrile phase 
 • Critical phase 
• Convalescent phase 
 
Febrile phase: 
The onset of dengue fever is usually with sudden rise in temperature 
which may be biphasic, lasting 5-8 days and commonly associated with 
headache, flushing and rash. There may be pain in retro-orbital area, 
muscles, joint or bone. 
Rash may be maculopapular or rubelliform and usually appear after 
3 or 4 day of fever and commonly seen in face, neck and other part of the 
body which generally fades away in the later part of the febrile phase. 
Localized cluster of petechiae may appear over upper and lower limbs. 
 During the first 24-48 hours of fever, children may develop a 
transient generalized macular erythematous rash which blanches upon 
pressure. The convalescent rash of dengue fever appears about 2-3 days 
after defervescence. It is characterized by generalized confluent petechial 
rash which does not blanch upon pressure, with multiple small round islets 
of normal skin. It is otherwise called "white islands in a sea of red" 
 
Critical phase: 
DF/DHF patients usually go to critical phase after 3 to 4 days of 
onset of fever. During this critical phase plasma leakage and high 
haemoconcentration are documented and patients may develop 
hypotension. Abnormal haemostasis and leakage of plasma leads to 
shock,bleeding, accumulation of fluid in pleural and abdominal cavity. 
High morbidity and mortality in DHF/DSS are commonly associated with 
various organ involvements and metabolic derangement. The period of 
plasma leakage usually persists for 36-48 hrs. 
 
Convalescent phase:  
 
During the recovery phase the extracellular fluid which was lost due 
to capillary leakage returns to the circulatory system and signs and 
symptoms improve.  
 This phase occurs after 6-7 days of fever and last for 2-3 days. (48-
72 hours). Longer convalescence may be expected in some of the patients 
with severe shock, organ involvement and other complications which may 
require specific treatment. Patient may develop pulmonary oedema due to 
fluid overload if the fluid replacement is not optimized carefully 
Clinical evaluation of Dengue fever: 
• Blood pressure 
• Evidence of bleeding in skin or other sites 
• Hydration status 
• Evidence of increased vascular permeability-- pleural 
effusions, ascites 
• Tourniquet test -Inflate blood pressure cuff to a point midway 
between systolic and diastolic pressure for 5 minutes 
Positive test: 20 or more petechiae per 1 inch2 (6.25 cm2 ). 
Laboratory diagnosis 
• Virus isolation 
• Genome detection 
• Antigen detection 
• Serological diagnosis  
 
 
 Virus isolation : - cultured mosquito cells /mammalian cells used 
It is the gold standard“gold standard”. But it has low sensitivity and 
takes long detection time 
Genome detection : 
          1) nested RT-PCR 
          2) single step RT-PCR                   
          3)NASBA assay 
Antigen detection : 
           1) E/M antigen 
           2) NS I antigen 
Serological diagnosis : 
          1) ELISA 
            2) IgM & IgG antibody detection  
 
ELISA-based NS1 antigen tests 
Dengue NS1 antigen is a glycoprotein which is produced in both 
membrane-associated and secretion forms, is seen in the serum of 
patientsin the early stages of dengue viral infection. It is  a useful 
investigation for the diagnosis of acute dengue infection. It is a simple test 
that has specificity and high sensitivity. 
 NS1 appears in blood in early viremic stage itself. So it helps in early 
diagnosis of Dengue infection..The NS1 ELISA-based antigen assay is 
widely available. Its another use is that ,it can be used to distinguish 
Dengue infection from other Flavi virus infection. 
 
IgM-capture  (MAC-ELISA) 
In the past few years, MAC-ELISA is a test that is used commonly. It 
is a simple test that and doesn’t require any complicated equipment. Anti 
Human IgM that is already to the solid phase is used to detect the IgM 
Dengue antibodies in MAC-ELISA. Dengue antigen is added to this, if the 
IgM antibody from the patient's serum is anti-dengue,then  it will bind to 
dengue antigen. Dye added will make colour change if the antibody is 
present in serum. 
 
 
 
 
 
 
 
 Comparison of diagnostic tests according to their accessibility and 
confidence 
 
 
Interpretation of Dengue diagnostic tests   
Highly suggestive of Dengue : 
One of the following: 
IgM + in a single serum sample 
IgG + in a single serum sample 
with a HI titre of 1280 or greater 
Confirmed 
One of the following: 
 1) PCR +          
2) Virus culture +      
3) IgM seroconversion in paired sera      
4) IgG seroconversion in paired sera or fourfold IgG titer increase 
in paired sera 
Interpretation of dengue serology reports 
IgM IgG Interpretation 
Negative Negative Early sample/not dengue 
Negative Positive (low titre) Past dengue infection 
Negative Positive (high titre) Secondary dengue infection 
Positive Negative Primary dengue infection 
Positive Positive (low titre) Recent primary dengue 
infection 
Positive Positive (high titre) Secondary dengue infection 
 
Supportive investigations 
• Complete blood count (CBC) 
• Metabolic panel 
• Serum protein and albumin levels 
• Liver panel 
• Disseminated intravascular coagulation (DIC) panel 
 • Chest X-Rays - Effusion 
• USG Abdomen - Ascites 
Characteristic findings in dengue fever : 
• Thrombocytopenia (platelet count < 100 x 109/L) 
• Leukopenia 
• Mild to moderate elevation of aspartate aminotransferase and alanine 
aminotransferase values 
In patients with dengue hemorrhagic fever: 
• Increased hematocrit level secondary to plasma extravasation and/or 
third-space fluid loss 
• Hypoproteinemia 
• Prolonged prothrombin time 
• Prolonged activated partial thromboplastin time 
• Decreased fibrinogen Increased amount of fibrin split products 
Markers for severe disease : 
• Increased urinary levels of heparan sulphate 
• Increased plasma levels of pentraxin 3 
• Decreased serum albumin 
• Increased levels of vascular endothelial growth factor (VEGF) 
• Increased levels of soluble vascular cell adhesion molecule – 1 
(VCAM-1) 
 Differential diagnosis 
 • Dengue-like diseases [Chikungunya fever , West Nile fever (with 
rash) & Colorado tick fever, sandfly fever, Rift Valley fever, and 
Ross River fever (without rash)]  
• Early stages of malaria 
• Mild yellow fever 
• Viral hepatitis 
• Leptospirosis 
• Viral respiratory and influenza like diseases 
 
Outpatient management of a patient with dengue 
• Advise bed rest  
• Encourage plenty of oral fluid intake (of oral rehydration solution 
(ORS), fruit juice and other fluids containing electrolytes and sugar) 
• Give paracetamol for high fever if the patient is uncomfortable. 
• Inform the patient about the warning signs 
 
Indications for hospitalisation 
Suspect severe dengue and the need for hospitalisation when patient 
develops : 
• Giddiness 
• cooler extremities compared to trunk & extremities 
 • Oliguria with dark urine 
• Rt. hypochondriac pain or severe abdominal pain 
• Bleeding from any site 
• Persistent vomiting 
• Lethargy or irritability/restlessness 
Management of a patient with severe Dengue  
1) Replacement of plasma losses 
2) Recognition & management of hemorrhage 
3) Prevention and management of fluid overload 
4) Prevention of iatrogenic infections 
 
Initial management 
 • Establish IV access 
• Collect samples for blood group, Hb, PCV and platelets 
• Monitor : 
- Pulse volume 
- Blood pressure 
- Abdominal girth 
- Urine output 
 
 
 Crystalloids and colloids, normal saline and Ringer Lactate: 
 Colloids provide volume expansion over and above actual fluid 
volume infused. Crystalloids have no added volume effect. Major concerns 
with use of colloids are impact on coagulation and allergic reaction. Hence, 
crystalloids are ideal for initial resuscitation & colloids better serve in 
severe shock with undetectable blood pressure.  
NS preferred over RL due to risk of worsening tissue acidosis and 
lactate accumulation when large volumes of RL is infused repeatedly. 
Large volumes of 0.9% saline may lead to hyperchloraemic acidosis (this 
may aggravate or be confused with lactic acidosis from prolonged shock). 
When serum chloride level  increase the normal range, it is advisable to 
change to Ringer’s Lactate 
 
Management algorithm for Dengue Haemorrhagic fever Grade 1 and 11 
If the PCV rise of the patient is more than 20 % , have to initiate 
6ml/kg /hr crystalloid solution for 1-2hours. Then we have to repet 
haematocrit value. If there is improvement in haematocrit can decrease the 
dose of crystalloids  to 6 ml/kg/hr for 2-4 hours and then to 3ml/kg/hr for 2-
4 hrs and 3- 1.5ml/kg/hrfor 2-4hours. 
 
 If there is no improvement and PCV rises increase IV crystalloids to 
10 ml/kg/hr crystalloid for 2hours. If PCV falls blood transfusion is 
indicated  
 
Management of Dengue haemorrahgic fever Grade 111 
If the PCV rise of the patient is more than 20 %  and pulse pressure 
is <20 if SBP <90 have to start IV therapy with 10-20 ml/kg/hr , and if 
there is improvement in PCV then decrease infusion rate to 6ml/kg /hr 
crystalloid solution for 1-2hours. Then we have to repet haematocrit value. 
 If there is improvement in haematocrit can decrease the dose of 
crystalloids  to 6 ml/kg/hr for 2-4 hours and then to 3ml/kg/hr for 2-4 hrs 
and 3- 1.5ml/kg/hrfor 2-4hours. 
 
  
 
If there is no improvement and PCV rises increase IV crystalloids to 
10 ml/kg/hr crystalloid for 2hours. If PCV falls blood transfusion is 
indicated 
  
Management of Dengue haemorrahgic fever grade 1V 
If there is profound shock  or signs of shock undetectable Blood 
pressure and high PCV (20% rise) 
Volume replacement with 10- 20 ml /kg crystlloids over 15- 20 min. 
If there is improvement can decrease the rate of infusion to 10- 6 ml /kg for 
2 hours and 
Management of congestive phase 
• Change over to hypotonic fluid 
 • Decrease infusion rate to 3-5 ml/kg BW/hr 
• Diuretics & digitalisation needed in patients with cardiac overload 
due to regurgitant fluid 
Management of DF with co-infections 
It is difficult to manage Dengue Fever when there are associated 
infections like HIV, Tuberculosis , chikungunya, malaria, enteric fever and 
leptospira. Manifestations will be severe in case of coinfections. 
 
HIV:  
In HIV and AIDS patients  may develop severe complications like 
Dengue Haemorrhagic Fever and Dengue shock syndrome. Bleeding 
manifestations  and organ involvement may occur in patients with HIV and 
dengue. In patients with very low  CD4 count prognosis of Dengue fever is 
poor. There is a possibility of multi system involvement in case of HIV 
coinfection. Expert advise is always required in management of such 
patients. 
 
Tuberculosis:  
Dyspnea and massive hemoptysis can occur as a complication of 
Dengue fever and Tuberculosis. Pleural effusion and Acute Respiratory 
Distress Syndrome can occur in Tuberculosis. Close monitoring should be 
done anticipating the complications.   
 Enteric Fever: 
 As Typhoid and gastroenteritis are water born diseases there is a 
possibility of coinfection with Dengue. In initial phase Dengue Fever, if 
antibiotic treatment is started late patient may become more complicated. 
Blood culture should be done as confirmatory test. Widal may be negative 
initial week.  
Malaria:  
Malaria is another mosquito born illness that can occur along with 
Dengue.As the management of malaria is entirely different that of dengue , 
it is important that early diagnosis of malria should be made.Treatment 
should be started early for better outcome. 
 
Chikungunya:  
Chikungunya is another mosquito born infection that is endemic in 
Dengue prevalent areas. Acute complications are more if there is 
coinfection. Chikungunya is characterized by joint pain. So in case of 
dengue fever if patient has polyarthralgia should suspect chikungunya 
coinfection. 
 
Pregnancy  and Dengue infection 
  Physiologicaly in pregnancy there is hemodilution , 
hypercoagulability and changes in cardiovascular status. Manifestations of 
 Dengue may confuse with complications in pregnancy too.  In HELLP 
syndrome there is thrombocytopenia, elevated liver function test and 
features of capillary leakage.  
 Maternal death due to  severe bleeding  at time of delivery 
may occur in patients with Dengue haemaorrhagic syndrome.  Abortion 
may occur due to dengue infection during first trimester 
Fetal death may occur due to placental insufficiency. Premature birth 
is another possibility. There can be neural tube defects also  
 
Management of dengue in new born 
If the neonate goes into shock septic septic shock or birth trauma is 
taken as the first differential diagnosis. History of febrile illness in  
pregnancy  may give a clue to the diagnosis of Dengue Shock Syndrome in 
new born and infants. Close monitoring andsupportive treatment is the 
mainstay of management. 
 
Management of dengue in infants 
Infants without warning signs: 
Together with breastfeeding/formula feeding oral rehydration should 
be advised  with oral rehydration solution (ORS), fruit juice and other 
fluids with electrolytes and sugar. Parents or attenders have to be advised 
about fever control with paracetamol and tepid sponging. In case of any 
 warning signs care givers should be advised to bring the child immediately 
to health care set up. 
Infants with warning signs: 
If the infant develops any warning sign it is an indication for 
intravenous rehydration. Volume replacement with intravenous fluid 
therapy has to be done judiciously. At first  isotonic crystalloid solutions 
like Ringer's lactate, Ringer's acetate, or 0.9% saline solution can be used. 
In majority of the infants capillary leak resolves sitself after 24-48 hours. 
 
Infants with severe dengue:  
Treatment of shock is by volume replacement in  dengue shock. It is very 
challenging  issue and hence has to be done judiciously. Every case has to 
be critically evaluated separately. 
Dengue viral hepatitis:  
Some patients develop abnormality of liver function test due to 
dengue viral infection. AST/ALT level may be very high in some  and 
prothrombin time may be prolonged. Liver involvement is usually seen 
with pre-existing conditions like chronic viral hepatitis, cirrhosis  and 
haepatomegaly due to other causes. Patient may also go for hepatic 
encephalopathy because of acute liver failure. Liver dysfunction may occur 
with DF in pregnancy. Low serum albumin in chronic liver disease may be 
 associated with severe Dengue Haemorrhagic Fever and bleeding 
manifestations. Gastrointestinal  bleeding is may occur in this and there can 
be severe Dengue shock syndrome. Careful management with hepatic 
failure regimen and appropriate  intravenous fluids and blood transfusion. 
If there is prothrombin time prolongation  IV vitamin K1 may be started in 
such conditions. 
Dengue myocarditis:  
Dengue infection can cause acute myocarditis rarely. This  may 
contribute to the development of Dengue Shock Syndome. Cardiac 
complications are more seen in patients with Coronary artery disease, 
systemic hypertension, diabetes and valvular heart disease. Management of 
shock with IV fluid should be done carefully in patients with cardio 
vascular compromise. Improper management may result in pulmonary 
edema. Coronary Artery disease patient who are already on Aspirin and 
other anti-platelet agent may develop severe bleeding if these drugs are not  
stopped in dengue infection. There should be frequent monitoring of the 
cardiac status and electrolye balance in these patients. Proper monitoring 
and treatment should be given for patients with biventricular failure 
forbetter morbidity and mortality outcome. 
 
 
 Dengue Fever in Diabetes:  
Diabetic patients may develop severe complication in Dengue Fever 
especially when there is micro vascular or macro vascular complications 
like diabetic retinopathy, nephropathy, neuropathy , cardiomyopathy, 
vasculopathy and hypertension. There can be uncrontolled blood sugar in 
Dengue fever requiring treatment with insulin. 
Central nervous system involvement in Dengue Fever:  
Altered sensorium may develop in dengue patient due to various 
conditions like shock , electrolyte imbalance because of persistent 
vomiting, fluid overload leading to dilutional hyponatremia or other 
electrolyte imbalance, hypoglycemia, hepatic enchalopathy and also due to 
direct  involvement of the Central nervous system by the virus.  
There can be disseminated demyelination following dengue infection 
and cause acute disseminated encephalomyelitis. In some patients there can 
be acute encephalopathy. Cerebral  Malaria and enteric encephalopathy  are 
close differential diagnosis which may also occur in same period . Dengue 
serology (IgM) in Cerebro spinal fluid sample maybe of help to confirm 
dengue encephalitis. 
Renal involvement in Dengue Fever: 
 Acute Tubular Necrosis (ATN) may occur in Dengue Shock 
Syndrome and  acute kidney injury (AKI) may develop if fluid therapy is 
 not given adequately on time. If shock is corrected renal function may be 
reversible, in short duration. If there is persistent shock there can be renal 
complications.  Monitoring of urine output is very important  in dengue 
infection to assess renal function. Urine routine examination also should be 
done to look for any microscopic haematuria. Other blood investigations 
like serum urea,creatinine, electrolytes, Glomerular Filtration Rate, Arterial 
Blood Gas analysis has to be done in patients with severe dengue and 
Dengue Haemorrhage Fever. Fluid intake has to monitored closely in case 
of Acute Kidney Injury so as to avoid volume overload and pulmonary 
oedema. Patients with diabetic nephropathy , systemic hypertension and 
connective tissue disorders are at high risk of development of dengue 
haemorragic fever. 
 
 
 
 
 
 
 
 Summary of publications 
1) Title : Sonography in the diagnosis and assessment of dengue fever 
Journal published :Journal of clinical  imaging science 2014 march 
Authors: V R Santhosh, Prasanth G Patil, MG srenath, Ashok kumar, 
Aditi Jain , M Archana 
 Conclusion: Sonographic features of thickened gall bladder wall, 
pleural effusion, ascites , hepatomegaly and splenomegaly strongly 
favour the diagnosis of dengue in patients presenting with fever and 
associated features, especially during an epidemic. The degree of 
thrombocytopenia showed a direct relationship with ultrasound 
findings 
2) Title:Can Radiology play a role in early diagnosis of Dengue fever? 
Journal published : North American Journalof Medical Sciences  
Authors :Sruti Chandak, Ashtosh Kumar                       
Conclusion : Ultrasoud features of hepatospleenomegaly , GB wall 
edema , right sided or bilateral pleural effusion and ascites in patients 
presenting with signs and symptoms of DF during an epidemic are 
virtually diagnostic of DF. There have been recent changing trends 
with hepatospleenomegaly being the more common manifestation in 
comparison to ascites and GB wall edema. Dengue fever has the 
 catastrophic effects in pregnancy such as oligohydramnios and intra 
uterine fetal demise. 
3) Title : Is ultrasound a useful tool to predict severity of  Dengue  
infection  
 Journal published : Indian journal of Pediatrics 2016 
 Authors: Pothapregada S , Kullu, Kamaakkannan , Thulasingam M 
 Conclusion :Ultrasound can be used as an early predictor as well as an 
important prognostic sign for severe dengue infection especially 
during an epidemic 
4) Title : Role of ultrasound in assessment of dengue fever  
 Journal published :Indian Journal of scientific study 2016  
Authors :K S Vedaraju1, K R Vijay Kumar1, T V Vijayaraghavachari 
 Conclusion : USG is an important accessory tool for the early 
diagnosis of plasma leakage signs and for prediction of the disease 
severity, identifying mild and severe cases of dengue hemorrhagic 
fever, besides contributing in the differential diagnosis with other 
causes of febrile disease. 
5) Title : Ultrasound findings in Dengue fever  
Journal published :Internatinal Journal of Recent Trends in Science 
and Technology 2016 
Authors :Omprakash Bhangdia, Suresh Bhattad, Krithi Bhangdia  
 Conclusion :Abdomoinal ultrasound should be made a routine 
investigation in cases of Dengue fever as it helps in clinical diagnosis 
and early detection of complications 
6) Title : Role of ultrasound in Dengue Fever  
 Journal published : British Journal of Radiology 2005  
 Authors : PM Venkitasai B Dev, R Krishnan 
 Conclusion : Ultrasound abdomen is n impotant adjunct in diagnosis 
of Dengue and may help to direct further confirmatory investigations 
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 MATERIALS AND METHODS 
 
STUDY POPULATION: 
100 patients with serologically proven Dengue fever more than 13 
years of age 
 
STUDY SETTING: 
Department of General Medicine, Government Rajaji Hospital & 
Madurai Medical College, Madurai. 
 
SAMPLE SIZE : 
100 IgM positive Dengue patients 
 
Inclusion Criteria 
• History of fever  
• IgM dengue positive 
• Age > 13 years 
 
Exclusion Criteria  
• Chronic liver disease   
• Cholilithiasis  
• Chronic renal failure 
• Congestive cardiac failure 
• ITP  
 STUDY TOOL: 
A predesigned proforma was used to collect information of the study 
participants. The proforma had questions to collect information about the 
socio – demographic details of the participants, clinical history and signs 
suggestive of Dengue fever. Proforma also had details of estimated lab 
parameters like Complete Hemogram,  basic biochemical investigations 
,IGM Dengue and Ultasonographic findings of the patient 
 
ANTICIPATED OUTCOME: 
Ultrasound can pick up evidence of plasma leakage early. So that 
careful monitoring can be done to prevent profound shock 
 
DATA COLLECTION: 
Informed consent will be obtained from all patients to be enrolled for 
the study. In all the patients relevant information will be collected in a 
predesigned proforma. The patients are selected based on clinical 
examinations and biochemical tests. 
 
Adult patients aged more than 13 years of age admitted with fever 
with IgM Dengue positive serology in the Department of Medicine of 
Government Rajaji Hospital, Madurai will be subjected to ultrasound 
abdomen, pelvis and chest .  Platelet and hematocrit values,  and blood 
pressure monitoring will be done  
 STATISTICAL ANALYSIS: 
The collected data will be entered in Microsoft Excel spreadsheet 
and analyzed using Statistical Package for Social Sciences (SPSS) version 
Patients with a platelet count of less than 1 lakh was considered to 
have thrombocytopenia. Rise in PCV of 20 % was taken as significant rise 
in PCV and fall in pulse pressure to less than 20 was taken as significant. 
And the presence of bleeding manifestation in history too is considered. 
Each of these 4 parameters – ( bleeding manifestations , fall in pulse 
pressure , rise in PCV and thrombocytopenia ) will be compared with each 
of the described ultrasonographic findings – (thickened gall bladder, 
pericholecystic fluid,pleural effusion ascites, perinephric edema, 
hepatomegaly and splenomegaly) 
 
The analysis of data was carried out by entering the coded 
information and generating tables. Statistical analysis was done using chi 
square tests and p value was found. 
 
LABORATORY INVESTIGATIONS 
a) Complete Hemogram 
b) Peripheral blood smear 
c) Liver function test 
d) Renal function test 
 e) Fasting and Post prandial blood Sugar 
f) IgM Dengue 
 
DESIGN OF STUDY: 
Cross sectional study 
PERIOD OF STUDY: 
3 MONTHS  
COLLABORATING DEPARTMENTS: 
DEPARTMENT OF BIOCHEMISTRY 
DEPARTMENT OF RADIOLOGY 
DEPARTMENT OF PATHOLOGY 
DEPARTMENT OF MICROBIOLOGY 
ETHICAL CLEARANCE: Study proposal accepted by institute ethical 
committee ,MADURAI MEDICAL COLLEGE 
CONSENT: Individual written and informed consent obtained. 
ANALYSIS: Statistical analysis will be performed using appropriate tests 
as required according to data. 
CONFLICT OF INTEREST: NIL 
FINANCIAL SUPPORT:  self 
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 RESULTS AND INTERPRETATION 
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Study was conducted among 100 serologically proven Dengue fever cases among 
which 48 were females and 52 were males . The mean age was 37 years. 
Minimun age was 14 and maximum was 74 years 
 
Ultra sonographic findings 
 
Most common ultrasound finding is gall bladder wall thickening. Next 
common finding is pericholecystic fluid. Least common finding is 
splenomegaly 
 Most common laboratory parameter was thrombocytopenia present in 63 of 
100 patients. But bleeding manifestations were present only in 27 patients.  
Rise in PCV was seen in 34 patients33 and a fall in pulse in 33. 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 24.900a 1 .000   
Continuity Correctionb 22.620 1 .000   
Likelihood Ratio 33.389 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 24.709 1 .000   
N of Valid Casesb 130     
 
While comparing splenomegaly and thrombocytopenia chi square value 
was found to be 24.9 . with a degree of freedom of one p value was <0.01. 
Hence there is a statistically significant association between splenomegaly 
and thrombocytopenia 
Splenomegaly Vs thrombocytopenia 
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 Hepatomegaly Vs thrombocytopenia  
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 32.043a 1 .000   
Continuity Correctionb 29.641 1 .000   
Likelihood Ratio 42.486 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 31.797 1 .000   
N of Valid Casesb 130     
 
While comparing hepatomegaly and thrombocytopenia chi square value 
was found to be 32.043. With a degree of  freedom of one p value was 
found to be <0.01. Hence there is a statistically significant association 
between heoatomegaly and thrombocytopenia. 
 Perinephric edema Vs thrombocytopenia  
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 40.119a 1 .000   
Continuity Correctionb 37.712 1 .000   
Likelihood Ratio 46.849 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 39.810 1 .000   
N of Valid Casesb 130     
 
While comparing perinephric edema and thrombocytopenia chisquare value 
was found to be 40.119. With degree of freedom of one P value was found 
to be <0.01. Hence there is a statistically significant association between 
between perinepric edema and thrombocytopenia 
  
 Ascitis Vs thrombocytopenia  
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 60.417a 1 .000   
Continuity Correctionb 57.552 1 .000   
Likelihood Ratio 77.609 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 59.952 1 .000   
N of Valid Casesb 130     
 
While comparing ascites with thrombocytopenia there is a chi square value 
of 60.417. With a degree of freedom of one P value was found to be <0.01. 
Hence there is a statistically significant association between ascites and 
thrombocytopenia. 
 
 Pleuraleffusion Vs thrombocytopenia  
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 75.153a 1 .000   
Continuity Correctionb 72.080 1 .000   
Likelihood Ratio 91.053 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 74.575 1 .000   
N of Valid Casesb 130     
 
While comparing pleural effusion and thrombocytopenia Chi Square value 
was found to be 75.153. With degree of freedom of one P value was found 
to be <0.01. Hence there is a statisticaly significant association between 
pleural effusion and thrombocytopenia. 
 
 PericholicyticFuid Vs  thrombocytopenia  
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 68.650a 1 .000   
Continuity Correctionb 65.768 1 .000   
Likelihood Ratio 77.115 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 68.122 1 .000   
N of Valid Casesb 130     
 
While comparing pericholecystic fluid and thrombocytopenia Chi Square 
value value was found to be 68.650. With a degree of freedom of one P 
value was found to be <0.01 
 
 
 Thickened gall bladder Vs thrombocytopenia  
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 65.120a 1 .000   
Continuity Correctionb 62.310 1 .000   
Likelihood Ratio 72.088 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 64.619 1 .000   
N of Valid Casesb 130     
 
While comparing thickening of gall bladder and thrombocytopenia Chi 
Square value was found to be 65.120. With a degree of freedom of one P 
value was found to be <0.01. Hence there is a statistically significant 
association between gall bladder thickening and thrombocytopenia. 
 
 Splenomegaly Vs haematocrit rise 
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 10.270a 1 .001   
Continuity Correctionb 8.649 1 .003   
Likelihood Ratio 9.275 1 .002   
Fisher's Exact Test    .003 .002
Linear-by-Linear Association 10.191 1 .001   
N of Valid Casesb 130     
 
While comparing splenomegaly and PCV rise Chi square value was found 
to be 10.270. With a degree of freedom of one P value was found to be < 
0.01.Hence there is a statistically significant association between 
splenomegaly and PCV rise. 
 
 Hepatomegaly  Vs haematocrit rise 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 7.803a 1 .005   
Continuity Correctionb 6.501 1 .011   
Likelihood Ratio 7.208 1 .007   
Fisher's Exact Test    .008 .007
Linear-by-Linear Association 7.743 1 .005   
N of Valid Casesb 130     
 
While comparing hepatomegaly and PCV rise Chi square value was found 
to be 7.803. With a degree of freedom of one P value was found to be < 
0.01.Hence there is a statistically significant association between 
hepatomegaly and PCV rise. 
 
 Perinephricedema Vs haematocrit rise 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 35.833a 1 .000   
Continuity Correctionb 33.278 1 .000   
Likelihood Ratio 34.077 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 35.558 1 .000   
N of Valid Casesb 130     
 
While comparing perinephric edema and PCV rise Chi square value was 
found to be 35.833. With a degree of freedom of one P value was found to 
be < 0.01.Hence there is a statistically significant association between 
perinephric edema  and PCV rise. 
 
 Ascitis Vs haematocrit rise 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 36.742a 1 .000   
Continuity Correctionb 34.239 1 .000   
Likelihood Ratio 35.864 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 36.460 1 .000   
N of Valid Casesb 130     
 
While comparing ascitis and PCV rise Chi square value was found to be 
36.742. With a degree of freedom of one P value was found to be < 
0.01.Hence there is a statistically significant association between ascitis 
and PCV rise 
 
 Pleural effusion Vs haematocrit rise 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 47.080a 1 .000   
Continuity Correctionb 44.352 1 .000   
Likelihood Ratio 49.741 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 46.718 1 .000   
N of Valid Casesb 130     
 
While comparing pleural effusion  and PCV rise Chi square value was 
found to be 47.080. With a degree of freedom of one P value was found to 
be < 0.01.Hence there is a statistically significant association between 
pleural effusion and PCV rise. 
 
 PericholecyticFuid Vs haematocrit rise 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 33.357a 1 .000   
Continuity Correctionb 31.108 1 .000   
Likelihood Ratio 36.354 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 33.101 1 .000   
N of Valid Casesb 130     
 
While comparing pericholecystic fluid and PCV rise Chi square value was 
found to be 33.357. With a degree of freedom of one P value was found to 
be < 0.01.Hence there is a statistically significant association between 
presence of pericholecystic fluid and PCV rise. 
 
 Thickened gall bladder  Vs  haematocrit rise 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 31.517a 1 .000   
Continuity Correctionb 29.329 1 .000   
Likelihood Ratio 37.099 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 31.274 1 .000   
N of Valid Casesb 130     
 
While comparing thickened gall bladder  and PCV rise Chi square value 
was found to be 31.517. With a degree of freedom of one P value was 
found to be < 0.01.Hence there is a statistically significant association 
between thickened gall bladder  and PCV rise. 
 
 Splenomegaly Vs fall in pulse pressure 
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 10.270a 1 .001   
Continuity Correctionb 8.649 1 .003   
Likelihood Ratio 9.275 1 .002   
Fisher's Exact Test    .003 .002
Linear-by-Linear Association 10.191 1 .001   
N of Valid Casesb 130     
 
While comparing splenomegaly and fall in pulse pressure  Chi square value 
was found to be 10.270. With a degree of freedom of one P value was 
found to be < 0.01.Hence there is a statistically significant association 
between splenomegaly and fall in pulse pressure. 
 
 Hepatomegaly  Vs fall in pulse pressure 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 14.200a 1 .000   
Continuity Correctionb 12.422 1 .000   
Likelihood Ratio 12.955 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 14.091 1 .000   
N of Valid Casesb 130     
 
While comparing hepatomegaly and fall in pulse pressure  Chi square value 
was found to be 14.200. With a degree of freedom of one P value was 
found to be < 0.01.Hence there is a statistically significant association 
between hepatomegaly and fall in pulse pressure 
 
 Perinephricedema Vs  fall in pulse pressure 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 26.180a 1 .000   
Continuity Correctionb 24.002 1 .000   
Likelihood Ratio 24.772 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 25.978 1 .000   
N of Valid Casesb 130     
 
While comparing perinephric edema  and fall in pulse pressure  Chi square 
value was found to be 26.180. With a degree of freedom of one P value was 
found to be < 0.01.Hence there is a statistically significant association 
between perinephric edema and fall in pulse pressure 
 
 Ascitis Vs fall in pulse pressure 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 31.824a 1 .000   
Continuity Correctionb 29.497 1 .000   
Likelihood Ratio 30.912 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 31.579 1 .000   
N of Valid Casesb 130     
 
While comparing ascitis and fall in pulse pressure  Chi square value was 
found to be 31.824. With a degree of freedom of one P value was found to 
be < 0.01.Hence there is a statistically significant association between 
ascitis and fall in pulse pressure. 
 Pleuraleffusion and fall in pulse pressure 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 41.704a 1 .000   
Continuity Correctionb 39.138 1 .000   
Likelihood Ratio 43.451 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 41.383 1 .000   
N of Valid Casesb 130     
 
While comparing pleural effusion and fall in pulse pressure  Chi square 
value was found to be 41.704. With a degree of freedom of one P value was 
found to be < 0.01.Hence there is a statistically significant association 
between pleural effusion  and fall in pulse pressure. 
 
 PericholecyticFuid Vs fall in pulse pressure 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 24.832a 1 .000   
Continuity Correctionb 22.897 1 .000   
Likelihood Ratio 26.261 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 24.641 1 .000   
N of Valid Casesb 130     
 
While comparing pericholicystic fluid and fall in pulse pressure  Chi square 
value was found to be 24.832. With a degree of freedom of one P value was 
found to be < 0.01.Hence there is a statistically significant association 
between pericholicystic fluid collection  and fall in pulse pressure. 
 
 Thickened gallbladder Vs fall in pulse pressure 
 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 23.239a 1 .000   
Continuity Correctionb 21.366 1 .000   
Likelihood Ratio 25.932 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 23.060 1 .000   
N of Valid Casesb 130     
 
While comparing thickened gall bladder  and fall in pulse pressure  Chi 
square value was found to be 23.239. With a degree of freedom of one P 
value was found to be < 0.01.Hence there is a statistically significant 
association between the ultrasonographic finding of thickened gall bladder  
and fall in pulse pressure 
 
 Splenomegaly and  bleeding manifestations 
 
 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 8.963a 1 .003   
Continuity Correctionb 7.340 1 .007   
Likelihood Ratio 7.823 1 .005   
Fisher's Exact Test    .008 .005
Linear-by-Linear Association 8.894 1 .003   
N of Valid Casesb 130     
 
While comparing splenomegaly and bleeding manifestations  Chi square 
value was found to be 8.963. With a degree of freedom of one P value was 
found to be < 0.01.Hence there is a statistically significant association 
between splenomegaly and bleeding manifestations 
 Hepatomegaly and bleeding manifestations 
 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 7.435a 1 .006   
Continuity Correctionb 6.070 1 .014   
Likelihood Ratio 6.685 1 .010   
Fisher's Exact Test    .016 .009
Linear-by-Linear Association 7.378 1 .007   
N of Valid Casesb 130     
 
While comparing hepatomegaly and bleeding manifestations   Chi square 
value was found to be 7.435. With a degree of freedom of one P value was 
found to be < 0.01.Hence there is a statistically significant association 
between hepatomegaly and bleeding manifestations 
 Perinephric edema and bleeding manifestations 
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Chi-Square Tests 
 
Value Df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 41.998a 1 .000   
Continuity Correctionb 39.013 1 .000   
Likelihood Ratio 39.373 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 41.675 1 .000   
N of Valid Casesb 130     
 
While comparing perinephric edema and bleeding manifestations   Chi 
square value was found to be 41.998. With a degree of freedom of one P 
value was found to be < 0.01.Hence there is a statistically significant 
association between perinephric edema and bleeding manifestations 
 Ascites and bleeding manifestations 
 
 
 
Chi-Square Tests 
 
Value Df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 38.811a 1 .000   
Continuity Correctionb 36.038 1 .000   
Likelihood Ratio 37.788 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 38.513 1 .000   
N of Valid Casesb 130     
 
While comparing ascites  and bleeding manifestations   Chi square value 
was found to be 38.811. With a degree of freedom of one P value was 
found to be < 0.01.Hence there is a statistically significant association 
between ascites  and bleeding manifestations 
 Pleural effusion and bleeding manifestations 
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 47.347a 1 .000   
Continuity Correctionb 44.397 1 .000   
Likelihood Ratio 52.750 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 46.982 1 .000   
N of Valid Casesb 130     
 
While comparing pleural effusion and bleeding manifestations   Chi square 
value was found to be 47.347. With a degree of freedom of one P value was 
found to be < 0.01.Hence there is a statistically significant association 
between pleural effusion and bleeding manifestations. 
 Pericholecytic fluid and bleeding manifestations 
 
 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 30.233a 1 .000   
Continuity Correctionb 27.928 1 .000   
Likelihood Ratio 34.125 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 30.000 1 .000   
N of Valid Casesb 130     
 
While comparing pericholecystic fluid  and bleeding manifestations   Chi 
square value was found to be 30.233. With a degree of freedom of one P 
value was found to be < 0.01.Hence there is a statistically significant 
association between pericholecytic fluid  and bleeding manifestations. 
 Thick gall bladder and Bleeding manifestations 
 
 
Chi-Square Tests 
 
Value df 
Asymp. Sig. (2-
sided) 
Exact Sig. (2-
sided) 
Exact Sig. (1-
sided) 
Pearson Chi-Square 21.853a 1 .000   
Continuity Correctionb 19.898 1 .000   
Likelihood Ratio 25.564 1 .000   
Fisher's Exact Test    .000 .000
Linear-by-Linear Association 21.685 1 .000   
N of Valid Casesb 130     
 
While comparing thickened gall bladder and bleeding manifestations   Chi 
square value was found to be 21.853. With a degree of freedom of one P 
value was found to be < 0.01.Hence there is a statistically significant 
association between thickened gall bladder and bleeding manifestations. 
 
  
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 DISCUSSION: 
 
Dengue is at rapidly spreading viral disease in the world. In the last 
50 years, thete was a thirty fold increase in the incidence of Dengue . An 
estimated 50 million dengue infections occur annually. About 2.5 million 
people live in Dengue endemic areas in the world. 
In our study 48 % were females and 52% were males. And the mean 
age was 37 years. Among the 100 dengue patients studied 63 had 
thrombocytopenia but only 27 had bleeding manifestations. PCV rise was 
seen in 34 % and a fall in pulse pressure was seen in 33 %. 
Most common ultrasound finding was thickened gall bladder.. that 
was present in 70 % of the study population. Next common finding was 
pericholecystic fluid collection seen in 61 %. Pleural effusion was the third 
common finding. It was present in 50%. Ascitis was present in 43 % and 
perinephric edema in 36 %. Hepatomegaly was present in 24 % and 
splenomegaly in 19 percent. 
Only 63 % had thrombocytopenia and rise in PCV was seen only in 
34 %. But there was an ultrasonographic evidence of plasma leakage in the 
form of thickened gall bladder in 70 %.  
 
 
 In a similar study conducted during the epidemic in 1997 by Joshi et 
al., the most common age group affected was 20 to 40 years and right sided 
pleural effusion was the most common finding, like .In their study,the most 
common finding was pleural effusion .In their study, ascites was seen in 
only 50% of cases;  
Thickened GB wall was first reported as a fi nding of Dengue Fever 
by Pramuljo et al.[15] It has been found in a lot of studies to be a consistent 
and common ultrasound finding of Dengue Fever. Venkata Sai et al.[1] had 
found it in hundred percent  patients in their study as the most common 
firstl ultrasound finding. In fact, it has been propagated to be used in 
children as a reliable criterion to predict the onset. 
Similar to the study conducted by Venkata Sai et al our study too 
found thickened gall bladder as the most common finding .  
Javed et al. found hepatomegaly in 35.5% patients and splenomegaly 
in 28.9% patients.  In our study hepatomegaly and splenomegaly was seen 
only in 24 % and 19 % respectively. That was the least common among the 
ultrasound parameters studied. 
 
When comparing the statistical association, there was significant 
statistical association with  thrombocytopenia, PCV rise , fall in pulse 
pressure and all the 7 ultra sound parameters studied. 
  
   
 
 
 
 
 
 
CONCLUSION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Ultrasound abdomen can be used as a first line investigation 
modality in  dengue fever suspected patients especially in the scenario of an 
epidemic of Dengue as it can detect early signs suggestive of the disease. 
 Ultrasonogram of abdomen is useful for early prediction of the 
severity of dengue fever. Sonographic changes occurs even before a change 
appears in platelet count or haematocrit. Thus  ultasonography of abdomen 
helps in triage of cases and close monitoring can be done for those patients 
to prevent a profound dengue haemorragic fever and Dengue shock 
syndrome   
Ultrasound abdomen supported with lab parameters like rising 
haematocrit and decreasing platelet count predicts the progression to severe 
form of the disease.  
 
 
 
 
 
 
 
 
 
  
 
 
 
LIMITATIONS OF 
 
THE STUDY 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 LIMITATION 
 
• Study did not involve a follow up ultrasound and serial pulse 
pressure PCV and platelet monitoring. Hence the number of patients 
with earlier plasma leakage findings in ultrasound who have gone for 
further plasma leakage and shock could not be found. 
• Many patients had diabetes and hypertension which might have 
already damaged the capillary endothelium. Hence plasmaleakage in 
this patients may be severe even in early stages of dengue. This was 
not taken into account. 
RECOMMENDATIONS: 
1) Patients with clinical history suggestive of Dengue fever should be 
subjected to an ultrasonogram of abdomen pelvis and chest to look 
for evidence of any plasma leakage. 
2) Patients with evidence of plasma leakage in ultrasound may be 
admitted and monitored to prevent complications of Dengue shock 
syndrome 
3) Patients with associated comorbidities like Diabetes and 
Hypertension should be monitored more closely 
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PROFORMA 
 
 
 
 
 
 
 
 
 PROFORMA 
Name: 
Age / Sex: 
Occupation: 
Presenting complaints: 
 
Past History: 
H/o DM, HT, CKD, CVD, CLD 
Clinical Examination: 
General Examination: 
Consciousness 
Pallor 
Jaundice  
Clubbing  
Lymphadenopathy  
Hydration status 
 
Signs suggestive of thrombocytopenia and plasmaleakage: 
Petechie/ purpura over skin 
Palatal purpura 
Gum bleeding 
 
Vitals: 
PR 
BP 
RR 
SpO2 
 
 
 Systemic examination: 
CVS: 
RS: 
ABDOMEN: 
CNS: 
 
Laboratory investigations: 
a) Hemoglobin  
b) Hematocrit  
c) Peripheral Smear 
d) Liver function test 
e) Renal function test 
f) Random blood sugar 
 
IgM Dengue 
Ultrasound abdomen chest and pelvis 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
CONSENT FORM 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 ஆராᾼᾲசிஒᾺᾗத᾿பᾊவΆ 
 
ெபய᾽:     ேததி:  
வயᾐ:     ேநாயாளிஎᾶ:  
     
 ஆராᾼᾲசிேச᾽ᾰைகஎᾶ:  
  
இᾸதஆராᾼᾲசியிᾹவிவரᾱகᾦΆஅதᾹேநாᾰகᾱ
கᾦΆᾙᾨைமயாகஎனᾰᾁவிளᾰகப᾵டᾐ.  
  
எனᾰᾁவிளᾰகப᾵டவிஷயᾱகைளநாᾹᾗாிᾸᾐ
ெகாᾶᾌஎனᾐᾙᾨமனᾐடᾹசΆமதிᾰகிேறᾹ. 
  
இᾸதஆராᾼᾲசியி᾿பிறாிᾹநி᾽பᾸதமிᾹறிஎᾹெசா
ᾸதவிᾞᾺபᾷதிᾹேபாி᾿தாᾹபᾱᾁெபᾠகிேறᾹமιᾠΆ
நாᾹஇᾸதஆராᾼᾲசியி᾿இᾞᾸᾐஎᾸதேநரᾙΆபிᾹவாᾱ
கலாΆஎᾹᾠΆஅதனா᾿எᾸதபாதிᾺᾗΆஎனᾰᾁஏιபடா
ᾐஎᾹபைதᾜΆᾗாிᾸᾐெகாᾶேடᾹ.  
 
நாᾹஎᾹᾔைடயᾆயநிைனᾫடᾹமιᾠΆᾙᾨᾆதᾸதிரᾷ
ᾐடᾹஇᾸதமᾞᾷᾐவஆராᾼᾲசியி᾿பᾱᾁெகா῀ளசΆம
திᾰகிேறᾹ. 
 
 
 
 
 
 
 
 ABBREVIATIONS  
 
DF – Dengue fever 
DHF- Dengue haemorragic fever 
DHSS- Dengue shock syndrome 
PCV – packed cell volume 
HCT – Hematocrit 
NS1- Non Structural Protein 
PP- pulse pressure 
GB – gall bladder 
          CAD – Coronary artery disease 
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